Literature DB >> 8980612

Adhesion molecules in the dissemination of non-Hodgkin's lymphomas.

S T Pals1, P Drillenburg, T Radaszkiewicz, E Manten-Horst.   

Abstract

Most non-Hodgkin's lymphomas (NHLs) express a number of different adhesion receptors. A large body of evidence indicates that these adhesion receptors not only regulate normal lymphocyte trafficking but also play a pivotal role in the dissemination of NHL. Thus, cutaneous lymphocyte antigen, alpha 4 beta 7, alpha E beta 7, and L-selectin, which mediate the tissue-specific positioning of normal lymphocytes in the skin, mucosa, epithelium and lymph nodes, respectively, are selectively expressed on lymphomas localized at these sites. Furthermore, expression of CD44, a family of adhesion receptors with pleiotropic effects on tumor behavior, is related to lymphoma aggressiveness and dissemination. Taken together, these findings offer a framework for the understanding of tumor dissemination in NHL. In view of the similarities between lymphocyte behavior and the metastatic behavior of solid tumors, these insights might contribute to the understanding of the basic mechanisms underlying tumor metastasis in non-lymphoid tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8980612     DOI: 10.1159/000203662

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis.

Authors:  F Qian; D Hanahan; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Are selectins involved in metastasis?

Authors:  T Krause; G A Turner
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

3.  Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.

Authors:  A Tzankov; A-C Pehrs; A Zimpfer; S Ascani; A Lugli; S Pileri; S Dirnhofer
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.